Oxybutynin Chloride
- Product NDC
- 42291-914
- 11-digit product format
- 422910914
- Labeler code
- 42291
- Product ID
- 42291-914_e9e61f3d-53da-64e0-e053-2995a90aad21
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- oxybutynin chloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA075079
- Marketing category
- ANDA
- Marketing start
- 2022-09-30
- Marketing end
- 0000-00-00
- Substance
- OXYBUTYNIN CHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-914 | OXYBUTYNIN CHLORIDE TABLET [AVKARE] | 2 | Legacy NDC | 20240111_e9e61a32-d815-2fa3-e053-2a95a90a63ee.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-914-50 | 42291091450 | 500 TABLET in 1 BOTTLE (42291-914-50) | 500 tablet | 2022-09-30 | 0000-00-00 | No | No | Current |